AU2007206889A1 - Dicarbonylic compounds with antibacterial activity - Google Patents

Dicarbonylic compounds with antibacterial activity Download PDF

Info

Publication number
AU2007206889A1
AU2007206889A1 AU2007206889A AU2007206889A AU2007206889A1 AU 2007206889 A1 AU2007206889 A1 AU 2007206889A1 AU 2007206889 A AU2007206889 A AU 2007206889A AU 2007206889 A AU2007206889 A AU 2007206889A AU 2007206889 A1 AU2007206889 A1 AU 2007206889A1
Authority
AU
Australia
Prior art keywords
isoxazol
nre
fluoro
phenyl
piperazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007206889A
Other languages
English (en)
Inventor
Dolors Balsa Lopez
Juan Lorenzo Catena Ruiz
Jose Hidalgo Rodriguez
Carmen Lagunas Arnal
Isabel Masip Masip
Oscar Rey Puiggros
Carolina Salcedo Roca
Maria Del Carmen Serra Comas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Salvat SA
Original Assignee
Laboratorios Salvat SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Salvat SA filed Critical Laboratorios Salvat SA
Publication of AU2007206889A1 publication Critical patent/AU2007206889A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU2007206889A 2006-01-19 2007-01-18 Dicarbonylic compounds with antibacterial activity Abandoned AU2007206889A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200600158 2006-01-19
ES200600158 2006-01-19
PCT/EP2007/050489 WO2007082910A1 (en) 2006-01-19 2007-01-18 Dicarbonylic compounds with antibacterial activity

Publications (1)

Publication Number Publication Date
AU2007206889A1 true AU2007206889A1 (en) 2007-07-26

Family

ID=37781676

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007206889A Abandoned AU2007206889A1 (en) 2006-01-19 2007-01-18 Dicarbonylic compounds with antibacterial activity

Country Status (9)

Country Link
US (1) US20100075984A1 (https=)
EP (1) EP1976837A1 (https=)
JP (1) JP2009523764A (https=)
KR (1) KR20080108977A (https=)
CN (1) CN101405277A (https=)
AU (1) AU2007206889A1 (https=)
BR (1) BRPI0706938A2 (https=)
CA (1) CA2637052A1 (https=)
WO (1) WO2007082910A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5291292B2 (ja) * 2007-02-01 2013-09-18 協同油脂株式会社 金属加工用油剤及び金属加工方法
EP2367820B1 (en) * 2008-11-20 2016-09-21 Panacea Biotec Limited Novel antimicrobial agents
BR112012000657A2 (pt) 2009-06-26 2016-11-16 Panacea Biotec Ltd novos azabicilohexanos
WO2011002067A1 (ja) * 2009-07-02 2011-01-06 武田薬品工業株式会社 複素環化合物およびその用途
CN109503569B (zh) * 2019-01-03 2021-01-15 山东大学 噻唑类衍生物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2180456B1 (es) * 2001-07-20 2004-05-01 Laboratorios S.A.L.V.A.T., S.A. Isoxazoles sustituidos y su utilizacion como antibioticos.
MXPA05001199A (es) * 2002-07-29 2005-05-16 Ranbaxy Lab Ltd Derivados de oxazolidinona como antimicrobianos.
WO2005082892A2 (en) * 2004-02-17 2005-09-09 Dr. Reddy's Laboratories Ltd. Triazole compounds as antibacterial agents and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
US20100075984A1 (en) 2010-03-25
CN101405277A (zh) 2009-04-08
WO2007082910A1 (en) 2007-07-26
EP1976837A1 (en) 2008-10-08
CA2637052A1 (en) 2007-07-26
BRPI0706938A2 (pt) 2011-04-12
JP2009523764A (ja) 2009-06-25
KR20080108977A (ko) 2008-12-16

Similar Documents

Publication Publication Date Title
JP6352571B1 (ja) キナーゼ阻害剤としての複素環式アミド
CN104169275B (zh) 用作激酶抑制剂的三唑取代的吡啶化合物
CN104159896B (zh) 用作激酶抑制剂的杂环取代的吡啶基化合物
CN104254533B (zh) 用作激酶抑制剂的噻唑或噻二唑取代的吡啶基化合物
KR100463634B1 (ko) 항균성 헤테로바이사이클릭 치환된 페닐 옥사졸리디논
AU2003292828B2 (en) Diamine derivatives
JP7175888B2 (ja) 選択的ｈｄａｃ１、２阻害剤としてのピペラジン誘導体
JP2019532928A (ja) ベータラクタマーゼ阻害剤化合物
CA2803842A1 (en) Nicotinamide derivative or salt thereof as syk-inhibitors
CA2943858A1 (en) Trka kinase inhibitors, compositions and methods thereof
KR20090106604A (ko) 축합 피리딘 화합물
AU2007206889A1 (en) Dicarbonylic compounds with antibacterial activity
CN121851016A (zh) 含咪唑稠环类衍生物、其制备方法及其在医药上的应用
EP1358185A2 (en) Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
ES2312839T3 (es) Quinolinas y sus derivados nitrogenados y su uso como agentes antibacterianos.
CN108349947A (zh) 四氢吲唑及其医药用途
CN109574947A (zh) 含联芳基腙结构的噁唑烷酮类化合物及其制备方法
JP2023512823A (ja) ピロロ［２，３‐ｂ］ピリジン‐３‐カルボキサミド組成物及び聴力損失を改善するための方法
JP2023530337A (ja) 新規な融合複素環－カルボノヒドラゾノイルジシアニド化合物及びその用途
JP2023504730A (ja) Ｎ－（３－（５－（ピリミジン－４－イル）チアゾール－４－イル）フェニル）スルホンアミド化合物及びｂｒａｆ阻害剤としてのそれらの使用
RU2802283C2 (ru) Новый ингибитор на основе производного хинолина
WO2022096990A1 (en) Novel hetrocyclic compounds
CN121930235A (zh) 含咪唑稠环类衍生物、其制备方法及其在医药上的应用
CN120817958A (zh) 苯并呋喃类化合物及其制备方法和应用
WO2015071780A1 (en) Alkylidine substituted heterocyclyl derivatives as anti-bacterial agents

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application